TGFB1 and diabetic kidney disease: Wang et al. reported that Astragaloside IV (a bioactive saponin extracted from Astragalus root) could inhibit the expression of miR-21 and miR-192 in DKD models and alleviate renal fibrosis by acting on the TGF-β1/Smad pathway [85,86].